Monday, September 12, 2016

U.S. Senate committee chair: Mylan's response on EpiPen price hike 'incomplete'

WASHINGTON, Sept 9 (Reuters) - The chairman of the U.S.

Senate Judiciary Committee probing Mylan NV's EpiPen

price hike on Friday said its response to his query was

"incomplete," and called on the...

Read more

No comments:

Post a Comment